Cargando…
The Clinical Efficacy of Multidose Oritavancin: A Systematic Review
Oritavancin (ORI) is a semisynthetic lipoglycopeptide approved as a single 1200 mg dose intravenous infusion for the treatment of acute bacterial skin and skin structure infections (ABSSSIs) caused by Gram-positive organisms in adults. The pharmacokinetic/pharmacodynamic (PK/PD) linear kinetic profi...
Autores principales: | Baiardi, Giammarco, Cameran Caviglia, Michela, Piras, Fabio, Sacco, Fabio, Prinapori, Roberta, Cristina, Maria Luisa, Mattioli, Francesca, Sartini, Marina, Pontali, Emanuele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604328/ https://www.ncbi.nlm.nih.gov/pubmed/37887199 http://dx.doi.org/10.3390/antibiotics12101498 |
Ejemplares similares
-
Antitumor Potential of Antiepileptic Drugs in Human Glioblastoma: Pharmacological Targets and Clinical Benefits
por: Stella, Manuela, et al.
Publicado: (2023) -
Impact of the COVID-19 Pandemic on Epidemiology of Antibiotic Resistance in an Intensive Care Unit (ICU): The Experience of a North-West Italian Center
por: Parisini, Andrea, et al.
Publicado: (2023) -
1553. Efficacy and Safety of Dalbavancin and Oritavancin in the Treatment of Gram-Positive Infections
por: Brown, Vanessa, et al.
Publicado: (2020) -
Deprescribing Strategies: A Prospective Study on Proton Pump Inhibitors
por: Calvini, Giulia, et al.
Publicado: (2023) -
Are multidose drug dispensing systems initiated for the appropriate patients?
por: Mertens, Bram J., et al.
Publicado: (2018)